Biocide products
Safety, efficacy, and risk assessment of GLP-compliant biocidal products
Biocidal products include disinfectants, preservatives, pesticides, and other antimicrobial products, and pose potential risks to human health and the environment. The GLP-compliant (Good Laboratory Practice) safety, efficacy, and risk assessment encompasses the determination of physicochemical properties and stability, the demonstration of efficacy against target microorganisms according to relevant standards, the identification of human health risks through toxicological studies, as well as exposure and risk characterization and environmental impact assessment in a holistic approach.
Biocidal products contain chemical or biological active substances used to control harmful organisms. The EU Biocidal Products Regulation (528/2012) and national legislation stipulate that these products must be assessed for efficacy, safety, and environmental risks before being placed on the market. A GLP-compliant study means that the organization of the test facility, quality assurance, standard operating procedures (SOPs), raw data collection, and the reporting and archiving processes comply with OECD GLP principles. GLP compliance is a fundamental prerequisite for data reliability and traceability; however, by itself, it does not imply scientific validity or regulatory approval.
1. Physicochemical properties and stability
The quality and safety of biocidal products depend on the correct determination of their chemical and physical properties. In GLP-compliant studies, the following parameters are evaluated:
Basic physicochemical properties such as pH, density, viscosity, flash point, solubility.
- Purity and stability of the active substance; identification of the active substance, degree of purity, and stability under storage conditions.
- Chemical integrity throughout the shelf life; monitoring of changes over time in the active substance and excipients, including their degradation products.
- Compatibility with packaging and migration testing; assessment of the product's interaction with the packaging material, the potential for migration, and the protective effect of the packaging.
2. Efficacy tests (biocidal activity)
Efficacy tests are designed according to the stated field of application of the product and the target microorganism species:
Bactericidal, fungicidal, virucidal, sporicidal, and mycobactericidal tests.
Standards such as EN 1276, EN 13697, and EN 14476 are fundamental reference standards for chemical disinfectants and antiseptics.
- Specific protocols for surface, hand, and air disinfectants are adapted to the application method and contact conditions.
- Tests under demanding conditions such as soil load, contact time, and temperature are designed to reflect actual conditions of use.
In GLP-compliant efficacy tests, the identification of the test microorganisms, the initial inoculum size, neutralization validation, positive and negative controls, reproducibility, and statistical evaluation must be documented in accordance with the SOPs. Efficacy results are interpreted in accordance with the field of application specified in the product's authorization dossier.
3. Toxicological evaluation (human health risks)
Human health risks are determined through GLP-compliant toxicological studies. The most important toxicological endpoints are:
- Acute toxicity (oral, dermal, inhalation).
Skin and eye irritation/corrosion.
Skin sensitization (allergic potential).
Repeated dose toxicity (28/90 days).
Genotoxicity (Ames test, micronucleus test).
Where applicable, carcinogenicity and reproductive toxicity.
4. Exposure and risk assessment
Risk analyses are carried out using separate scenarios depending on the type of user:
Separate scenarios for professional users and the general public.
Calculations of dermal, oral, and inhalation exposure; these are performed taking into account the type of application, concentration, duration, and frequency of use of the product.
- Software developed by ECHA, such as EUSES, is used in exposure and risk assessment.
- Risk characterization and limit values for safe use are determined by comparing exposure levels with acceptable reference values.
5. Environmental risk assessment
The environmental risk assessment of biocidal products covers the fate and effects of active substances and degradation products in the environment. Essential elements include:
Environmental fate; distribution, degradation, and accumulation in soil, water, and air.
Ecotoxicity; acute and chronic effects on aquatic and terrestrial organisms.
- PEC/PNEC ratios (predicted environmental concentration / predicted no-effect concentration) for risk characterization.
- Exposure scenarios; these are modeled according to the product's field of application, release pathways, and environmental media.
For all details and inquiries, please feel free to contact us.

